3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
3
Desmoid Tumors
3
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Disease
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Unresectable Solid Tumors
1
Thyroid Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Respiratory Aspiration
1
Pancreatic Adenocarcinoma Locally Advanced
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypesthesia
1
High-Burden Metastatic Solid Tumors
1
Interventions
Gemcitabine
32
Cisplatin
31
durvalumab
15
pembrolizumab
14
Fluorouracil
13
Oxaliplatin
12
Leucovorin
12
Capecitabine
10
Bevacizumab
8
lenvatinib
7
Nivolumab
7
zanidatamab
4
Trastuzumab
4
S 1 (combination)
4
Paclitaxel
4
Liquid Biopsy
4
Irinotecan
4
Carboplatin
4
Albumin-Bound Paclitaxel
4
tremelimumab
3
tislelizumab
3
irinotecan sucrosofate
3
Injections
3
Folfox protocol
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
pertuzumab
2
niraparib
2
ivosidenib
2
envafolimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Cryosurgery
×
1 year
×
Clear all
No trials found.